A comprehensive review has been released on novel drug targets and emerging therapies for rheumatoid arthritis. However, it is unclear what specific findings or breakthroughs the review contains, as reports from various outlets mention different areas of research, including microbes, metabolomic profiles, and genome mapping, with some focusing on other conditions such as osteoarthritis, psoriatic arthritis, and ulcerative colitis. The review's exact focus and conclusions are not clearly defined across the different reports.